Abstract
Study objectives Sleep disorders are common non-motor symptoms of Parkinson’s disease (PD) that significantly impact patients’ quality of life. Specifically, alterations in sleep microstructure – such as reduced slow-wave activity and sleep spindles - are prevalent in PD. The locus coeruleus (LC), the brain’s primary source of noradrenaline, plays a pivotal role in regulating both sleep and wakefulness and is highly vulnerable to neurodegeneration in PD. This study explores whether disruptions in sleep microarchitecture in PD are linked to LC degeneration.
Methods We assessed polysomnography for sleep macroarchitecture, EEG spectral power, and spindle density in 32 PD patients and 24 age- and sex-matched controls. In a subset of the sample, neuromelanin-sensitive MRI was performed, and LC neuromelanin contrast was correlated to sleep metrics.
Results PD patients exhibited reduced slow-wave activity (p < 0.01), slow to fast frequency ratio (p < 0.01) and spindle density (p < 0.05) compared to HC subjects. LC neuromelanin contrast was diminished in PD patients (p < 0.05). Even though group differences were detected for slow-wave activity, a positive correlation between LC contrast and spindle density but not slow-wave activity was observed in the entire sample.
Conclusions The findings indicate that spindle density, but not slow-wave activity, is associated with LC degeneration. Further research is needed to determine whether, besides this association, noradrenergic dysfunction is causal for impaired sleep microarchitecture and whether this connection also contributes to cognitive decline in PD and other neurodegenerative diseases, such as Alzheimer’s disease.
Statement of significance This study provides novel evidence linking degeneration of the locus coeruleus with reduced sleep spindle density in Parkinson’s disease. While sleep macroarchitecture remains largely intact in Parkinson’s disease, our findings highlight the importance of investigating sleep microstructure to understand disease-related sleep disturbances. Given the role of the locus coeruleus in regulating sleep and cognition, our results suggest that sleep spindle alterations may serve as a biomarker for noradrenergic dysfunction. Future research should explore whether these changes contribute to cognitive decline in Parkinson’s disease and other neurodegenerative diseases. Longitudinal studies are needed to assess the potential of sleep microstructure as an early marker of disease progression and a target for therapeutic interventions.
Competing Interest Statement
G. R. Fink serves as an editorial board member of Cortex, Neurological Research and Practice, NeuroImage: Clinical, Zeitschrift fuer Neuropsychologie, and DGNeurologie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, and SOP Neurologie; received honoraria for speaking engagements from Bayer, Desitin, Ergo DKV, Forum fuer medizinische Fortbildung FomF GmbH, GSK, Medica Academy Messe Duesseldorf, Medicbrain Healthcare, Novartis, Pfizer, and Sportaerztebund NRW.
Funding Statement
C. E. J. Doppler received grants from the Clinician Scientist Program (CCSP), funded by the German Research Foundation (DFG, FI 773/15-1). M. Sommerauer received grants from the Else Kroener-Fresenius-Stiftung (grant number 2019_EKES.02), and funding from the program "Netzwerke 2021", an initiative of the Ministry of Culture and Science of the State of North Rhine Westphalia. The Federal Ministry of Education and Research (BMBF) is funding the project within the framework of the funding programme ACCENT (funding code 01EO2107). G.R.F. is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 431549029 - SFB 1451.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Aarhus University and University of Cologne gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The data underlying this article will be shared on reasonable request to the corresponding author.
